Dec 01, 2020-Tuesday

select city

Metro cities - Delhi, Mumbai, Chennai, Kolkata

Other cities - Noida, Gurgaon, Bengaluru, Hyderabad, Bhopal , Chandigarh , Dehradun, Indore, Jaipur, Lucknow, Patna, Ranchi

Tuesday, Dec 01, 2020

Bharat biotech

Nov 27, 2020 15:33
Dr Parul Bhatt, the medical superintendent of the Sola Civil Hospital in Gujarat’s Ahmedabad, said the second dose of Bharat Biotech International Limited’s Covid-19 vaccine will now be given after 28 days. read more
Nov 27, 2020 07:44
Russia has suggested its vaccine candidate, Sputnik V, can be combined with AstraZeneca’s candidate to boost latter’s efficacy. Canada, meanwhile, could approve Pfizer Inc’s vaccine candidate in December. read more
Nov 26, 2020 07:56
China National Biotec Group Company has applied to Chinese health regulators to bring its candidate to the market. In Brazil, meanwhile, America’s Pfizer Inc has started the process to get its candidate registered. read more
Nov 23, 2020 08:35
The United Kingdom could give approval to Pfizer’s vaccine candidate this week, a report claimed. Meanwhile, the official Twitter account of Russia’s vaccine candidate Sputnik V claimed the price per dose of the vaccine would be “much lower” than that of Moderna and Pfizer’s vaccine candidates. read more
Nov 21, 2020 08:11
Britain’s AstraZeneca has launched phase three trials of an antibody combination drug, called AZD7442, that it hopes could be used to protect those at risk of contracting the coronavirus disease for up to 12 months. read more
Nov 20, 2020 13:43
Vij, who also holds the state home portfolio, had volunteered to be the first candidate for the trial shot of Covaxin. Bharat Biotech has started conducting phase 3 trials of the vaccine candidate. read more
Nov 20, 2020 08:27
Adar Poonawalla, the chief executive of Serum Institute of India, said his company may sell Covishield, the Covid-19 vaccine being developed by Oxford University, for around Rs 500-600 per shot. read more
Nov 19, 2020 23:44
The company recently announced that it had started phase 3 trials for its vaccine candidate which is India’s first vaccine candidate against Covid-19. read more
Nov 17, 2020 22:52
The two include the widely watched Oxford-AstraZeneca vaccine being tested by Serum Institute of India and the domestically developed candidate by Bharat Biotech. read more
Nov 17, 2020 08:42
Meanwhile, Johnson and Johnson has launched a second phase 3 trial, besides its existing one. Also, India is reportedly in talks with several firms over their respective coronavirus vaccine candidates with regards to the progress of trials, vaccine efficacy, safety etc. read more
Nov 17, 2020 02:58
The trial will be conducted in partnership with the Indian Council of Medical Research (ICMR), the Hyderabad-based drugmaker said in a statement. read more
Nov 06, 2020 09:29
Hungary has said it will import small doses of Russian-made Sputnik V for late stage trials, by December. Meanwhile, Australia has agreed to buy 50 million more doses of two more vaccine candidates. read more
Nov 02, 2020 08:08
AstraZeneca, meanwhile, has said Britain’s health regulator has started an ‘accelerated’ review. Its vaccine candidate is called ‘AZD1222’ and is being developed in partnership with the University of Oxford. read more
Nov 01, 2020 11:27
The company’s vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated Sars-Cov-2, the virus that causes Covid-19. The virus was isolated in an ICMR lab. read more
Oct 24, 2020 08:28
Covaxin is India’s first vaccine candidate against Covid-19 read more